We are live on ! Find out more

377 hedge funds and large institutions have $2.19B invested in Chemours in 2016 Q3 according to their latest regulatory filings, with 53 funds opening new positions, 87 increasing their positions, 134 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

233% more funds holding in top 10

Funds holding in top 10: 310 (+7)

88% more capital invested

Capital invested by funds: $1.16B → $2.19B (+$1.03B)

75% more call options, than puts

Call options by funds: $32.8M | Put options by funds: $18.8M

23% more first-time investments, than exits

New positions opened: 53 | Existing positions closed: 43

2% more funds holding

Funds holding: 371377 (+6)

1.76% less ownership

Funds ownership: 77.86%76.1% (-1.8%)

35% less repeat investments, than reductions

Existing positions increased: 87 | Existing positions reduced: 134

Holders
377
Holders Change
+6
Holders Change %
+1.62%
% of All Funds
10.06%
Holding in Top 10
10
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+233.33%
% of All Funds
0.27%
New
53
Increased
87
Reduced
134
Closed
43
Calls
$32.8M
Puts
$18.8M
Net Calls
+$14M
Net Calls Change
+$16.2M
Name Holding Trade Value Shares
Change
Change in
Stake
GC
1
Greenlight Capital
New York
$262M -$488K -42,700 -0.3%
Vanguard Group
2
Vanguard Group
Pennsylvania
$262M +$10.7M +934,243 +6%
BFA
3
BlackRock Fund Advisors
California
$210M +$10.7M +934,559 +8%
SC
4
Sessa Capital
New York
$125M -$10.6M -928,400 -11%
GC
5
GMT Capital
Georgia
$93.9M -$30.1M -2,638,274 -31%
BIT
6
BlackRock Institutional Trust
California
$73.8M +$360K +31,548 +0.7%
State Street
7
State Street
Massachusetts
$63.4M -$706K -61,799 -2%
GCM
8
Gates Capital Management
New York
$50.5M -$8.46M -740,551 -19%
SFM
9
Systematic Financial Management
New Jersey
$48.8M +$34.8M +3,049,089 New
Norges Bank
10
Norges Bank
Norway
$43.9M +$9.56M +836,862 +41%
Bank of New York Mellon
11
Bank of New York Mellon
New York
$43.3M +$1.87M +163,893 +6%
PMG
12
Private Management Group
California
$40.8M -$7.32M -641,384 -20%
Northern Trust
13
Northern Trust
Illinois
$34.3M -$36.2K -3,172 -0.1%
FCP
14
Fine Capital Partners
New York
$32.3M +$10.8M +942,929 +88%
AA
15
AQR Arbitrage
Connecticut
$31.9M +$2.39M +209,288 +12%
MCO
16
MAK Capital One
New York
$31.6M -$9.26M -810,874 -29%
Fidelity Investments
17
Fidelity Investments
Massachusetts
$30.1M +$17M +1,484,536 +376%
Goldman Sachs
18
Goldman Sachs
New York
$24.1M +$4.89M +428,001 +40%
Principal Financial Group
19
Principal Financial Group
Iowa
$21.5M +$456K +39,904 +3%
PAS
20
Point72 Asia (Singapore)
Singapore
$20.6M +$14.7M +1,285,000 New
Geode Capital Management
21
Geode Capital Management
Massachusetts
$20.1M +$610K +53,402 +4%
AQR Capital Management
22
AQR Capital Management
Connecticut
$19.2M -$2.93M -256,683 -18%
SCM
23
Schneider Capital Management
Pennsylvania
$18.4M +$13.2M +1,152,599 New
California Public Employees Retirement System
24
California Public Employees Retirement System
California
$18.3M +$1.52M +132,700 +13%
Invesco
25
Invesco
Georgia
$18.2M +$6.96M +609,716 +116%

CC Hedge Fund Activity: Q3 2016 in Review

377 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q3 2016, worth a combined $2.19B — up 88% from $1.16B a quarter earlier.

Buyers outnumbered sellers: 53 funds opened new CC positions and 43 closed out — a net gain of 10 holders — while 87 added to existing stakes and 134 trimmed.

The largest buyer was Systematic Financial Management, opening a new position worth an estimated $34.8M. The largest seller was Capital Research Global Investors, exiting entirely with an estimated $39.1M sold.

  • 377 institutional investors held Chemours (CC) as of Q3 2016, up from 371 in Q2 2016.
  • Funds reported $2.19B of Chemours stock for Q3 2016, up 88% quarter-over-quarter.
  • 53 funds opened new Chemours positions in Q3 2016 and 43 closed out, a net change of +10 holders.
  • The largest Chemours buyer in Q3 2016 was Systematic Financial Management, an estimated $34.8M added.
  • The largest Chemours seller in Q3 2016 was Capital Research Global Investors, an estimated $39.1M sold.

Based on aggregated 13F filings for Q3 2016.